Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Living Cell Technologies ( (AU:1AI) ) has shared an announcement.
Algorae Pharmaceuticals Limited reported a 13% increase in total revenue and other income for the year ended June 30, 2025, reaching $141,050. The company also saw a significant reduction in net loss after tax, which decreased by 62% to $802,958, primarily due to an R&D tax refund, decreased share-based payments, increased interest on funds, and lower administration expenses. No dividends were declared for the current or previous financial periods.
More about Living Cell Technologies
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$13.5M
Learn more about 1AI stock on TipRanks’ Stock Analysis page.